<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhan W</submitter><funding>NCI NIH HHS</funding><pagination>1565-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3249659</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(8)</volume><pubmed_abstract>A conformationally restrained epothilone A analogue (3) with a short bridge between methyl groups at C6 and C8 was designed and synthesized. Preliminary biological evaluation indicates 3 to be only weakly active (IC50 = 8.5 microM) against the A2780 human ovarian cancer cell line.</pubmed_abstract><journal>Organic letters</journal><pubmed_title>Design and synthesis of C6-C8 bridged epothilone A.</pubmed_title><pmcid>PMC3249659</pmcid><funding_grant_id>R01 CA069571</funding_grant_id><funding_grant_id>R01 CA069571-13</funding_grant_id><funding_grant_id>CA 69571</funding_grant_id><funding_grant_id>R01 CA069571-12</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Brodie PJ</pubmed_authors><pubmed_authors>Kingston DG</pubmed_authors><pubmed_authors>Liotta DC</pubmed_authors><pubmed_authors>Snyder JP</pubmed_authors><pubmed_authors>Zhan W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design and synthesis of C6-C8 bridged epothilone A.</name><description>A conformationally restrained epothilone A analogue (3) with a short bridge between methyl groups at C6 and C8 was designed and synthesized. Preliminary biological evaluation indicates 3 to be only weakly active (IC50 = 8.5 microM) against the A2780 human ovarian cancer cell line.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Apr</publication><modification>2025-04-19T13:48:55.218Z</modification><creation>2019-03-27T00:47:33Z</creation></dates><accession>S-EPMC3249659</accession><cross_references><pubmed>18355076</pubmed><doi>10.1021/ol800422q</doi></cross_references></HashMap>